Literature DB >> 26985320

Discovery of G Protein-Biased EP2 Receptor Agonists.

Seiji Ogawa1, Toshihide Watanabe2, Isamu Sugimoto2, Kazumi Moriyuki2, Yoshikazu Goto2, Shinsaku Yamane2, Akio Watanabe2, Kazuma Tsuboi2, Atsushi Kinoshita2, Hideo Kigoshi3, Kousuke Tani2, Toru Maruyama2.   

Abstract

To identify G protein-biased and highly subtype-selective EP2 receptor agonists, a series of bicyclic prostaglandin analogues were designed and synthesized. Structural hybridization of EP2/4 dual agonist 5 and prostacyclin analogue 6, followed by simplification of the ω chain enabled us to discover novel EP2 agonists with a unique prostacyclin-like scaffold. Further optimization of the ω chain was performed to improve EP2 agonist activity and subtype selectivity. Phenoxy derivative 18a showed potent agonist activity and excellent subtype selectivity. Furthermore, a series of compounds were identified as G protein-biased EP2 receptor agonists. These are the first examples of biased ligands of prostanoid receptors.

Entities:  

Keywords:  EP2; Prostaglandin; agonist; biased ligand; structure−functional selectivity relationship

Year:  2016        PMID: 26985320      PMCID: PMC4789666          DOI: 10.1021/acsmedchemlett.5b00455

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  24 in total

1.  Discovery of novel prostaglandin analogs as potent and selective EP2/EP4 dual agonists.

Authors:  Tohru Kambe; Toru Maruyama; Yoshihiko Nakai; Hideyuki Yoshida; Hiroji Oida; Takayuki Maruyama; Nobutaka Abe; Akio Nishiura; Hisao Nakai; Masaaki Toda
Journal:  Bioorg Med Chem       Date:  2012-02-16       Impact factor: 3.641

2.  Biased ligand modulation of seven transmembrane receptors (7TMRs): functional implications for drug discovery.

Authors:  Craig C Correll; Brian A McKittrick
Journal:  J Med Chem       Date:  2014-04-29       Impact factor: 7.446

3.  Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation.

Authors:  Keiji Yoshida; Hiroji Oida; Takuya Kobayashi; Takayuki Maruyama; Masaharu Tanaka; Teruaki Katayama; Kojiro Yamaguchi; Eri Segi; Tadao Tsuboyama; Mutsumi Matsushita; Kosei Ito; Yoshiaki Ito; Yukihiko Sugimoto; Fumitaka Ushikubi; Shuichi Ohuchida; Kigen Kondo; Takashi Nakamura; Shuh Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-26       Impact factor: 11.205

4.  Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia.

Authors:  Dong Liu; Liejun Wu; Richard Breyer; Mark P Mattson; Katrin Andreasson
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

5.  The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways.

Authors:  Kyung-Soo Chun; Huei-Chen Lao; Robert Langenbach
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

6.  Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1.

Authors:  M Katsuyama; R Ikegami; H Karahashi; F Amano; Y Sugimoto; A Ichikawa
Journal:  Biochem Biophys Res Commun       Date:  1998-10-29       Impact factor: 3.575

7.  The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke.

Authors:  Muzamil Ahmad; Sofiyan Saleem; Zahoor Shah; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Exp Transl Stroke Med       Date:  2010-07-08

8.  Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemia.

Authors:  Jun Li; Xibin Liang; Qian Wang; Richard M Breyer; Louise McCullough; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2008-04-20       Impact factor: 3.046

9.  Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

Authors:  Louise McCullough; Liejun Wu; Norman Haughey; Xibin Liang; Tracey Hand; Qian Wang; Richard M Breyer; Katrin Andreasson
Journal:  J Neurosci       Date:  2004-01-07       Impact factor: 6.167

10.  Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.

Authors:  Kimberly O Cameron; Bruce A Lefker; Hua Z Ke; Mei Li; Michael P Zawistoski; Christina M Tjoa; Ann S Wright; Shari L DeNinno; Vishwas M Paralkar; Thomas A Owen; Li Yu; David D Thompson
Journal:  Bioorg Med Chem Lett       Date:  2009-01-23       Impact factor: 2.823

View more
  3 in total

1.  BiasNet: A Model to Predict Ligand Bias Toward GPCR Signaling.

Authors:  Jason E Sanchez; Govinda B Kc; Julian Franco; William J Allen; Jesus David Garcia; Suman Sirimulla
Journal:  J Chem Inf Model       Date:  2021-08-16       Impact factor: 6.162

2.  Direct Cα-heteroarylation of structurally diverse ethers via a mild N-hydroxysuccinimide mediated cross-dehydrogenative coupling reaction.

Authors:  Shihui Liu; Aoxia Liu; Yongqiang Zhang; Wei Wang
Journal:  Chem Sci       Date:  2017-03-24       Impact factor: 9.825

3.  Novel high-throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors.

Authors:  Patrick Sieber; Anny Schäfer; Raphael Lieberherr; François Le Goff; Manuel Stritt; Richard W D Welford; John Gatfield; Oliver Peter; Oliver Nayler; Urs Lüthi
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.